Kester Capital

Founded in 2007, Kester Capital is a UK-based private equity firm specializing in mid-market investments. It focuses on buyouts and growth capital for companies seeking institutional funding for the first time, with a typical investment size of £5-25 million. The firm targets businesses across various sectors including healthcare, technology, media, and business services.

Sophie Corrodi

Associate

Daisy Driscoll

Associate

David Fernie

Vice President

Patricia Hamel

COO

Robert Henderson

Principal

Thomas Holroyd

Partner

Abhishek Majumdar

Partner

Jack Murphy

Associate

Peter Ralph

Partner

Cam Steele

Vice President

Ben Woolley

Principal

23 past transactions

Re-Flow

Private Equity Round in 2025
Re-Flow is a Devon-based company specializing in field management software for construction, highways, traffic management, civil engineering, rail, and landscaping sectors. Its award-winning platform offers digital job packs, scheduling, assignment of operatives, customizable forms for regulatory compliance, real-time data communication, and automated workflows. Trusted by industry leaders like M.V. Kelly, Colas, and BMI, Re-Flow has helped over 180 firms enhance their field management efficiency.

Emas Pharma

Acquisition in 2024
Emas Pharma is a global contract research organization specializing in clinical research services. It offers expertise in early phase trials, pharmacovigilance, regulatory affairs, strategic consultancy, medical affairs, and post-marketing surveillance. The company supports pharmaceutical and biotech industries worldwide through its offices in the UK, USA, Canada, Ireland, and Australia.

GXP Engaged Auditing Services

Acquisition in 2023
GXP Engaged Auditing Services is an accounting and auditing firm that provides QM auditing and consultancy services.

MAP Patient Access

Acquisition in 2023
MAP Patient Access is a pharmaceutical manufacturing firm that specializes in market access consulting services for the pharmaceutical and biotech sectors. The company offers a range of services, including early engagement, pricing strategy, health economics, outcomes research, and evidence communication. By providing these services, MAP Patient Access assists its clients in navigating the complex healthcare reimbursement processes globally, ensuring they can effectively position their products in the market.

DC Byte

Acquisition in 2022
DC Byte is a developer of a comprehensive data and analytics platform tailored for the data center sector. The platform offers a complete view of the market, encompassing both colocation and self-build enterprise assets. It integrates user-generated data from data center operators with proprietary researched content, ensuring that the information remains continuously updated and validated in real-time. This unique combination of data and advanced analytics equips clients with insights ranging from broad global perspectives to detailed granular information, facilitating informed decision-making within the data center industry.

Optibrium

Private Equity Round in 2022
Optibrium is a software company that specializes in providing innovative solutions for small molecule design, optimization, and data analysis, aimed at enhancing the drug discovery process. Founded in 2009 and headquartered in Cambridge, UK, with an additional office in Boston, US, the company’s flagship product, StarDrop, is a comprehensive and user-friendly software suite that facilitates the integration of data, predictive modeling, and decision-making in research. This tool enables users to streamline their workflow from data analysis to compound synthesis, thereby increasing the speed and efficiency of drug discovery. Optibrium collaborates with a diverse range of clients, including leading pharmaceutical companies, biotech firms, and academic institutions, to continuously develop new technologies and improve productivity in drug development.

Rephine

Acquisition in 2021
Rephine is a global consultancy firm specializing in audit services for the pharmaceutical, medical device, and biotechnology industries. It focuses on Good Manufacturing Practice (GMP) and Good Clinical Practice (GCP) audits, regulatory consulting, and GMP training.

Optibrium

Private Equity Round in 2021
Optibrium is a software company that specializes in providing innovative solutions for small molecule design, optimization, and data analysis, aimed at enhancing the drug discovery process. Founded in 2009 and headquartered in Cambridge, UK, with an additional office in Boston, US, the company’s flagship product, StarDrop, is a comprehensive and user-friendly software suite that facilitates the integration of data, predictive modeling, and decision-making in research. This tool enables users to streamline their workflow from data analysis to compound synthesis, thereby increasing the speed and efficiency of drug discovery. Optibrium collaborates with a diverse range of clients, including leading pharmaceutical companies, biotech firms, and academic institutions, to continuously develop new technologies and improve productivity in drug development.

You Garden

Acquisition in 2019
You Garden Limited is an online retailer based in Kings Lynn, United Kingdom, specializing in a wide range of gardening products. Founded in 2011, the company offers an extensive selection of flowers, trees, shrubs, fruits, and vegetables, as well as gardening machinery and gifts tailored for gardening enthusiasts. With a focus on providing quality products, You Garden aims to cater to the diverse needs of gardeners, enhancing their gardening experience.

VIXIO Regulatory Intelligence

Private Equity Round in 2019
VIXIO provides independent, authoritative intelligence on global regulatory developments within the payments and gambling industries. It helps businesses make informed decisions to mitigate risk and capitalize on new opportunities.

ComplianceOnline

Acquisition in 2019
ComplianceOnline is the provider of legal, regulatory and business intelligence for the gambling and payments industries. We specialise in providing high level and independent insights, analysis, data and research through our primary services GamblingCompliance and PaymentsCompliance. Through our advanced web-based technology platform we provide industry professionals with the critical information they need to understand what regulatory change today means for the business opportunities of tomorrow. We pride ourselves on providing the most comprehensive, accurate and up-­to-­date information services and eLearning courses. Based in London, Washington, D.C., California and Taipei, ComplianceOnlines’s team of in-house analysts and journalists boast an unrivaled network of contacts among policymakers, lobbyists and legal experts, as well as a wealth of experience to analyse what regulatory change and market developments today, means for business opportunities tomorrow. Our clients include global law firms and legal professionals, regulators, advisory communities, online and terrestrial operators, lotteries, financial institutions, fintech and start-up companies, and payment technology and service providers. Learn more at: https://gamblingcompliance.com/ https://paymentscompliance.com/

CETA Insurance

Acquisition in 2017
CETA Insurance is a leading provider of personal and commercial insurance distribution services in the United Kingdom. The company specializes in offering a diverse range of insurance products sourced from some of the UK's top insurance providers. CETA employs a tech-enabled online broking platform that facilitates efficient distribution and enhances the customer experience. Additionally, the company supports insurers with tools for quoting, selling, and processing their business, along with an introducer scheme that allows partners to earn income without engaging directly in policy sales. CETA's strong digital marketing capabilities and deep data insights have positioned it as an innovator in the insurance market, fostering recurring customer relationships and establishing a solid presence in its core channels.

Avania

Private Equity Round in 2016
Avania is a full-service contract research organization dedicated to managing clinical studies for a range of products, including medical devices, in vitro diagnostics, biologics, and combination products. The company specializes in providing tailored contract research services specifically for the medical device sector, guiding clients through all phases of product development, from feasibility studies to post-approval trials. Avania's expertise encompasses advanced technologies and novel products, enabling it to offer customized and scalable solutions that enhance operational efficiencies and facilitate the progression of medical technology on an international scale.

Frontier Medical Group

Private Equity Round in 2013
Frontier Medical Group is a manufacturer and supplier of healthcare consumables for providers in the UK, Europe and internationally. The company specializes in pressure area care and infection control products, including sharps disposal containers, clinical waste disposal containers, harm reduction products, and tools for pressure ulcer prevention, aiming to deliver safer, durable solutions that support infection control and patient care across healthcare settings.

Garrets International

Acquisition in 2012
Garrets International provides outsourced marine catering management for the commercial shipping industry. It manages approximately 1,000 vessels on behalf of major shipping clients and offers maritime provision management designed to reduce administration costs. The company delivers hygiene and food safety programs, food management, and storage management, along with training for cooks, procurement support, and crew welfare and retention services. These offerings aim to support nutrition, minimize food waste, and streamline onboard operations for vessel owners and managers.

AgriBriefing

Acquisition in 2012
AgriBriefing is a business media company specializing in pricing, data, marketing solutions, news, market intelligence, and insight for the global agriculture industry. Founded in 2010 by seasoned media executives Neil Thackray & Rory Brown, it provides proprietary data and critical market intelligence to producers, traders, and buyers of agricultural commodities, helping clients make better-informed decisions.

Industry Dynamics

Private Equity Round in 2011
Industry Dynamics is a business-to-business events organizer that specializes in hosting a diverse array of medium and large scale events. Operating primarily in Europe and North America, the company focuses on key sectors such as energy, pharmaceuticals, food and beverage, supply chain, and business services. In addition to event organization, Industry Dynamics provides training and online lead generation services, enhancing its offerings to clients and participants in various industries.

Chiltern International

Private Equity Round in 2010
Chiltern International Limited is a prominent contract research organization that specializes in clinical development and scientific services for the pharmaceutical and biotechnology sectors. The company offers a comprehensive range of services, including early and late-phase clinical development, biostatistics, and medical and regulatory affairs. Chiltern serves various specialty areas within the biopharmaceutical and medical device industries, utilizing diverse engagement models to meet the specific needs of its clients. In addition to its clinical services, Chiltern also provides resourcing solutions to support the operational requirements of its partners. Through its expertise and collaborative technologies, the company plays a crucial role in advancing clinical research and development.

Chiltern International

Acquisition in 2010
Chiltern International Limited is a prominent contract research organization that specializes in clinical development and scientific services for the pharmaceutical and biotechnology sectors. The company offers a comprehensive range of services, including early and late-phase clinical development, biostatistics, and medical and regulatory affairs. Chiltern serves various specialty areas within the biopharmaceutical and medical device industries, utilizing diverse engagement models to meet the specific needs of its clients. In addition to its clinical services, Chiltern also provides resourcing solutions to support the operational requirements of its partners. Through its expertise and collaborative technologies, the company plays a crucial role in advancing clinical research and development.

Travel Entertainment Group

Private Equity Round in 2008
Travel Entertainment Group, Ltd. provides entertainment services to the airline industry.

Ironshore Insurance

Private Equity Round in 2007
Ironshore Insurance, established in 2006 and headquartered in Hamilton, Bermuda, specializes in providing commercial property and casualty insurance products globally, including in the United States and Bermuda. The company offers a diverse range of coverages, such as professional and management liability, environmental and specialty casualty insurance, aviation, political risk, and surety products. Additionally, Ironshore caters to specific sectors including real estate, hospitality, and energy, while also underwriting catastrophic excess casualty and healthcare insurance. Certain specialty coverages are underwritten at Lloyd’s through Ironshore’s Pembroke Syndicate 4000. The company is recognized for its strong financial standing, holding an A (Excellent) rating from A.M. Best. Ironshore operates primarily in the wholesale market, focusing on complex and unique risks, and is committed to delivering customized insurance solutions and improved claims outcomes. As of May 2017, Ironshore operates as a subsidiary of Liberty Mutual Group.

Xanthus Pharmaceuticals

Series B in 2006
Xanthus Pharmaceuticals Inc. is a biopharmaceutical company dedicated to the discovery, development, acquisition, and commercialization of small-molecule therapeutics. The company primarily focuses on creating innovative treatments for cancer and autoimmune disorders, aiming to address unmet medical needs in these areas. Through its research and development efforts, Xanthus Pharmaceuticals strives to advance therapeutic options that can improve patient outcomes and enhance the quality of care in oncology and immunology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.